Aktie A1KCTT STEMGEN, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen StemGen, Inc. Other OTC

Aktien

A1KCTT

US85858B1098

SGNI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
D3eSports Announces REV3AL Partnership for Virtual-to-Real E-Racing Programs
D3eSports Announces Supporting Partnership With United States Esports Federation (USEF)
D3eSports Announces Supporting Partnership With United States Esports Federation
StemGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
STEMGEN, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW (form 10-Q)
D3eSports Announces TCG World For New eSports Series
D3eSports Proudly Announces First Hotel Resort Simulator Destination in Partnership with Newly Launched Team Jamaica
D3eSports Announces Team Jamaica for New eSports Series
D3eSports Announces Innocent Racing Team for D3eSports Cup Championship Series
StemGen Participates in South by Southwest (SXSW) Show
StemGen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021
STEMGEN, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW (form 10-Q)
StemGen, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021
STEMGEN, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW (form 10-Q)
D3eSports Looks Toward the Metaverse for Greater Engagement with “Virtual-to-Real” Racing Platform
D3eSports Announces Ember Labs as a Corporate Team for the 2022 D3eSports Cup Championship
D3eSports Announces CyberCon as Second Corporate Team for the 2022 D3eSports Cup Championship
D3eSports Announces First Corporate Team for the 2022 D3eSports Cup Championship
STEMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Stemgen, Inc. Reports Earnings Results for the Full Year Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1KCTT Aktie
  4. A1KCTT Aktie
  5. Nachrichten StemGen, Inc.
  6. Andere Sprachen